Sudarshan Chemical Allots 9.8 Lakh Shares Post Warrant Conversion
Sudarshan Chemical Industries allotted 9,80,000 equity shares upon conversion of warrants by Mr. Rajesh Balkrishna Rathi. The conversion followed the payment of the remaining 75% consideration at Rs. 1,019.75 per warrant. This increases the company's paid-up capital and Rathi's promoter shareholding to 6.32%.
The issuance of equity shares, while increasing the capital base, also dilutes existing shareholders' equity. The increase in promoter holding to over 6% is significant but not a controlling stake change. The impact is medium as it strengthens the capital structure and promoter alignment.
The allotment of shares upon conversion of warrants and the subsequent increase in promoter shareholding and paid-up capital is generally viewed positively as it indicates financial commitment and confidence in the company.
Sudarshan Chemical Industries Limited has announced the allotment of 9,80,000 equity shares following the conversion of warrants. These warrants were initially approved for issuance to Mr. Rajesh Balkrishna Rathi, a promoter and promoter group member, via a preferential issue through private placement.
The company had previously informed the stock exchanges on December 2, 2024, about the shareholders' approval for up to 9,80,000 warrants, each convertible into one fully paid-up equity share of face value Rs. 2, at a price of Rs. 1,019.75 per warrant. On December 13, 2024, the Fund Raising Committee of the Board had allotted these warrants, with 25% of the consideration (Rs. 254.94 per warrant, aggregating Rs. 24,98,41,200) received at the time of subscription.
Mr. Rathi has now exercised the conversion by remitting the remaining 75% of the consideration (Rs. 764.81 per warrant, aggregating Rs. 74,95,13,800). Consequently, the Allotment Committee, on June 10, 2026, approved the allotment of 9,80,000 equity shares to Mr. Rathi. These shares will rank pari-passu with existing equity shares and will be subject to a lock-in period as per SEBI ICDR Regulations.
Following this allotment, the company's paid-up equity share capital has increased from 7,86,27,576 shares amounting to Rs. 15,72,55,152 to 7,96,07,576 shares amounting to Rs. 15,92,15,152. The shareholding of Mr. Rajesh Balkrishna Rathi in the company has increased from 5.15% (40,50,359 shares) pre-conversion to 6.32% (50,30,359 shares) post-conversion. The issue price per equity share was Rs. 1,019.75, comprising a face value of Rs. 2 and a premium of Rs. 1,017.75.
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.